Human PRAME 69-83, LKAMVQAWPFTCLPL

The Human Melanoma antigen preferentially expressed in tumors (PRAME) Peptide (IEDB: 2230325) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Melanoma antigen preferentially expressed in tumors Peptide, H-LKAMVQAWPFTCLPL-OH (Uniprot: P78395 aa: 69-83) from JPT is produced under strict quality control and quality management.

Human PRAME 69-83, LKAMVQAWPFTCLPL - Specifications

• Peptide sequence: H-LKAMVQAWPFTCLPL-OH
• Amount: 10 mg (10 x 1 mg)
• Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
• Counterion: TFA
• Delivery Format: Freeze-dried in glass vial
• Application(s): T-cell Immunity
• Condition(s)/Topic(s): Melanoma
• Standard Delivery Time: approx. 3 weeks

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Request a Quote for you custom antigen peptide!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!